Scleromyxedema: A rare case report with dermoscopic findings
Indian Journal of Dermatology, Venereology and Leprology · 01.04.2023 · 90 · 96-98
DOI: 10.25259/ijdvl_740_2022 ↗Kurz gefasst
Fallbericht in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, online erschienen am 01.04.2023. Verfasst von Arjun Prakashey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Government Medical College, Bhavnagar, Gujarat, India. Hauptthemen laut MEDLINE: Scleromyxedema. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 1 Literaturangaben.
Abstract (Originalsprache)
The Indian Journal of Dermatology, Venereology and Leprology (IJDVL) is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Clinical and Experimental Dermatology, Cutaneous Biology, Dermatological Therapeutics, Cosmetic Dermatology, Dermatopathology, Dermatosurgery, Pediatric Dermatology, Photodermatology, HIV Medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Government Medical College, Bhavnagar, Gujarat, India.
- Department of Dermatology, Dermatopathology Research Center, Vyara, Tapi, Gujarat, India.
Zitieren
APA
Prakashey, A., Mehta, H., H Bharti, A., & Agharia, R. (2023). Scleromyxedema: A rare case report with dermoscopic findings. Indian Journal of Dermatology, Venereology and Leprology, 90, 96-98. https://doi.org/10.25259/ijdvl_740_2022
Vancouver
Prakashey A, Mehta H, H Bharti A, Agharia R. Scleromyxedema: A rare case report with dermoscopic findings. Indian Journal of Dermatology, Venereology and Leprology. 2023;90:96-98. doi:10.25259/ijdvl_740_2022
BibTeX
@article{Prakashey2023,
author = {Prakashey, Arjun and Mehta, Hita and H Bharti, Ankit and Agharia, Rashmiben},
title = {Scleromyxedema: A rare case report with dermoscopic findings},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2023},
volume = {90},
pages = {96--98},
doi = {10.25259/ijdvl_740_2022}
}
EUVIMED